Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Public Health, Environmental and Occupational Health,Pharmacology, Toxicology and Pharmaceutics (miscellaneous)
Reference8 articles.
1. Directive 2001/20/EC of the European Parliament and of the Council of 4 April 2001 on the Approximation of the Laws, Regulations and Administrative Provisions of the Member States Relating to the Implementation of Good Clinical Practice in the Conduct of Clinical Trials on Medicinal Products for Human Use (OJ L 121, 1.5.2001, p. 34).
2. van Doorn E, Hak E, Wilffert B. National differences in requirements for ethical and competent authority approval for a multinational vaccine trial under the EU Directive 2001/20/EC. Vaccines. 2015;3(2):263–92.
3. Regulation (EU) No 536/2014 of the European Parliament and of the Council of 16 April 2014 on Clinical Trials on Medicinal Products for Human Use, and Repealing Directive 2001/20/EC.
4. Gefenas E, Cekanauskaite A, Lekstutiene J, Lukaseviciene V. Application challenges of the new EU Clinical Trials Regulation. Eur J Clin Pharmacol. 2017;73(7):795–8.
5. Scavone C, di Mauro G, Pietropaolo M, Alfano R, Berrino L, Rossi F, Tomino C, Capuano A. The European clinical trials regulation (No 536/2014): changes and challenges. Expert Rev Clin Pharmacol. 2019;12(11):1027–32.